-
Merkle Releases Its Q1 2019 Digital Marketing Report
Post on 4/24/19
-
DrFirst Structures a New $17 Million Commercial Financing Facility with SunTrust
Post on 4/23/19
-
HealthWell Foundation Opens New Amyloidosis Fund
Post on 4/23/19
-
D4C Dental Brands Open New Offices in Laurel, Maryland
Post on 4/23/19
-
RegeneRx Publishes Annual Letter to Shareholders
Post on 4/22/19
-
Orgenesis Announces Collaboration Agreement with Columbia University
Post on 4/22/19
-
Lorien Health Services Voted “Best Elder Care” Company
Post on 4/22/19
-
GlycoMimetics Announces Publication of Nature Cell Biology Paper Supporting Recently Announced Clinical Trial of GMI-1359
Post on 4/22/19
-
Danaher's Q1 Looked Good, and a Big Acquisition Is on the Way
Post on 4/19/19
-
Cannabics Pharmaceuticals Announces Initiation of a Nationwide Clinical Study to Evaluate Antitumor Properties of Cannabinoid Compounds on Primary Cancer Biopsies
Post on 4/17/19
-
ivWatch Becomes Tech Center Research Park Anchor
Post on 4/17/19
-
RRD International Expands Clinical Pharmacology Capabilities
Post on 4/17/19
-
VCU Launches Center For Pharmaceutical Engineering And Sciences
Post on 4/17/19
-
Hampton Roads Medical Device Firm Raised Money, Expanding
Post on 4/17/19
-
2019’s Best & Worst States for Children’s Health Care – WalletHub Study
Post on 4/17/19
-
Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China
Post on 4/16/19
-
Alteon Health Expands Hospitalist Care To Long-Time Health System Partners
Post on 4/16/19
-
AllyAlign Health Raises $10M Round Led by McKesson Ventures
Post on 4/16/19
-
Paragon Biosciences Acquired By Catalent for $1.2 Billion
Post on 4/15/19
-
Novavax: I'll Take Capitulation And Despondency Before Hope
Post on 4/15/19
-
GlycoMimetics Announces Plans to Initiate Breast Cancer Trial to Evaluate GMI-1359
Post on 4/14/19
-
Rexahn Effects 1-for-12 Reverse Stock Split
Post on 4/14/19
-
Beltsville Based NextCure Readies IPO
Post on 4/14/19
-
ChoiceOne Urgent Care Partners with Coppermine Fieldhouse
Post on 4/11/19
-
Orgenesis Announces Collaboration and License Agreement for Exosome-Related Technologies with ExcellaBio
Post on 4/11/19